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1. In~od~ction 
Forssman substance is a heterophile antigen that 
specificalfy inhibits the reaction between sheep 
erythrocytes and anti-sheep erythrocyte antibody 
derived from different species [ 11. This substance has 
been shown to be a glycosphingolipid [2,3), and like 
ABH antigens associated with glycolipids occurs in 
multiple structural forms [4-h]. Three such variants, 
all bearing terminal GalNAc cy(X + 3)GalNAc struc- 
ture which determines the immunological specificity 
of Forssman antigen, occur in the dog gastric mucosa 
1451. 
Since blood group antigens of gastric mucosa are 
of glycosphingoiipid nature, while those of mucous 
secretions are associated with glycoproteins 171, we 
investigated the presence and the nature of Forssman 
antigen in the gastric mucus. These results show for 
the first time that the carbohydrate chains bearing 
Forssman antigenic determinant are associated with 
the mucus glycoproteins. 
2. Experimental 
2.1. Materials 
Dog stomachs, dissected immediately prior to 
mucus isolation, were obtained from the Hematolo~ 
Section of our school. Heterophile Forssman anti- 
serum was from Difco (Detroit MI). IDF cells for 
microimmunodiffusion and sheep red cells were pur- 
chased from Cordis (Miami FL). Forssman glycolipid 
(~obopenta~~cosylceramide) used here was prepared 
as in 141. Limpet ~-~-acetyigalactosam~n~dase [8] was 
donated by Drs S. C. Li and Y. T. Li (Tulane Univer- 
sity LA). Human red cells ABO types, human bIood 
grouping anti-A and anti-B serum, and anti-H lectin 
(Vkx e~~~~e~~ a glutinin I) were from Biolo~~al 
Corp. America (Port Reading NJ). Bio-Gel A-50m 
(So-100 mesh) was supplied by Bio-Rad (Richmond 
CA) and non-ionic detergent (Tergitol NP-40) by 
Sigma (St Louis MO). 
The surface mucus lining and preformed intracellu- 
lar mucus were obtained by inst~lation of the ligated 
stomach (antrum and fundus) with 2 M NaCI 191. The 
instillates were dialyzed against dist~led water, lyoph- 
ilized and dissolved, at 5 mg/ml solution, in 5 M guan- 
idine hydrochloride. The samples (10 ml portions) 
were introduced onto a Bio-Gel A-50 column 
(2.5 X 170 cm) and eluted with 0.5 M NaCl contain- 
ing 0.1% of Tergitol. The eluted fractions (5 ml) were 
assayed for glycoprotein as in [ 1 O], Fractions con- 
taining mucus ~ycoprotein were pooled, dialyzed and 
lyophilized. The dry samples were dissolved in a small 
volume of 0.5 M NaCl and separated from the resid- 
ual Tergitol by gel f~trat~on on a &o-Gel P-100 col- 
umn (2 X 170 cm) &ted with 0.5 M NaCl, dialyzed 
and lyophilized. Delipidation of mucus ~lycoproteins 
was performed with c~orofornl-methanol as in [l 11. 
2.3 + Analytical methods 
The carbohydrate components of the isolated 
glycoproteins and the lipid extracts were determined 
by gas-liquid ~~omatography following methanoly- 
sis, re-~-acetylation, and derivat~ation with s~ylating 
reagent using 3% SE-30 columns [l I]. The protein 
content was measured as in [ 12f and sulfate as in 
[I 31. Thin-layer ~l~romatography of the lipid extracts 
was performed on silica gel HL plates developed in 
chloroform-methanol-water (65/3518, by vol.) and 
the glycolipids were visualized with orcinol reagent. 
Removal of fucose from glycoproteins was accom- 
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plished by hydrolysis in 0.1 M trichloroacetic acid 
[ 141. Enzymatic digestion of glycoprotein fractions 
with Q-N-acetylgalactosaminidase was done as in [S]. 
Reactions were carried out in 0.05 M sodium citrate 
buffer, pH 4.0 at 37°C for 24 h. Following heat inac- 
tivation of enzyme, the liberated sugar recovered by 
dialysis was reduced, acetylated and quantified by 
gas-liquid chromatography [IS]. Alkaline degrada- 
tion of the studied glycoproteins and Forssman 
globopentaglycosylceramide was performed with 
0.5 M NaOH at room temperature for 60 h [7]. The 
alkali-treated samples were exhaustively dialyzed 
against distilled water and lyophilized. 
Sedimentation velocity and equilibrium studies 
were performed on a Beckman model E analytical 
ultracentrifuge at 20°C using double sector 12 mm 
interference centerpiece with Schliren and Rayleigh 
optics, and a diaphragm angle of 60” and 90”) respec- 
tively. The samples were dialyzed for 48 h against 
4 M guanidine hydrochloride containing 0.5 M NaCl. 
Sedimentation coefficient measurements were per- 
formed at 50 740 rev./min using samples at 5 mg/ml. 
Sedimentation equilibrium studies were carried out at 
6995 rev./min over 48 h at 0.4 mg/ml samples. A par- 
tial specific volume of 0.633 was used for the calcula- 
tion ofM, [16]. 
2.4. Immunological assays 
Hemagglutination and hemagglutination inhibition 
assays for ABH bloodgroup and Forssman activity 
were performed with the Takatsy microtitrator using 
0.025 ml loops, and 2% suspension of human and 
sheep red cells, respectively. The anti-A and anti-B 
sera were diluted to 4 units/O.025 ml, anti-H to 
2 units/O.025 ml and anti-Forssman serum to 8 units/ 
0.025 ml. Forssman activity was also tested by a 
double diffusion micromethod [ 171. The wells were 
filled with 10 ~1 of undiluted antiserum and 10 1.11 
2 mg/ml solutions of the glycoproteins in 0.2 M 
phosphate buffer (pH 7.0) containing 0.15 M NaCl. 
3. Results 
Application of the solubilized antral and fundic 
mucus to Bio-Gel A-50 columns yielded, in each case, 
2 peaks. The excluded M, peak contained mucus 
glycoprotein, while the included fraction represented 
-12% of the glycosubstance originally present in the 
solubilized mucus and consisted mainly of protein. 
202 
Table 1 
Chemical composition of dog antral and fundic mucus 
glycoprotein 
Component Relative weight (%) 
Antrum Fundus 
Fucose 8.72 5.56 
Galactose 12.73 13.54 
N-Acetylgalactosamine 17.11 15.09 
N-Acetylglucosamine 9.97 10.80 
Sialic acid” 3.55 5.53 
Sulfate 2.20 2.64 
Protein 38.10 36.80 
a Expressed as N-acetylneuraminic a id 
On sedimentation velocity analysis the mucus glyco- 
protein derived from antrum and fundus gave respec- 
tively single, broadening with time, peaks with cor- 
rected values of 6.9 S and 10.3 S. The M,. determina- 
tions by sedimentation equilibrium gave apparent 
value of 3.4 X 10’ for antrum glycoprotein and 
4.3 X 10’ for fundus glycoprotein. 
The chemical composition of the antral and fundic 
mucus glycoproteins is given in table 1. Carbo- 
hydrates constituted over 50% of the dry weight of 
each glycoprotein and consisted mainly of N-acetyl- 
galactosamine, galatose, N-acetylglucosamine, and 
fucose. Both glycoproteins exhibited higher content 
of N-acetylgalactosamine than N-acetylglucosamine. 
The ratios of the 2 were found to be 1.7: 1 for antral 
glycoprotein and 1.4: 1 for fundic glycoprotein. 
Neither glycoprotein contained glycosphingolipids, as 
judged by the results of thin-layer and gas chroma- 
tography analyses of their lipid extracts. Treatment 
of the antral glycoprotein with at-N-acetylgalactos- 
aminidase resulted in the loss of 26.4% of N-acetyl- 
galactosamine, while similar treatment of the fundic 
glycoprotein released 23.1% of N-acetylgalactos- 
amine. These data indicate that both glycoproteins 
contain oligosaccharide chains terminated with (Y-N. 
acetylgalactosamine. 
In the double diffusion micromethod, both glyco- 
proteins gave a single precipitation lines with anti- 
Forrsman antiserum which were fused with that of 
Forssman globopentaglycosylceramide lipid. In 
hemagglutination-inhibition assays the native and 
delipidated glycoproteins completely inhibited agglu- 
tination of sheep red cells by anti-Forssman anti- 
serum, and also showed a weak activity in human A 
Volume 130, number 2 FEBS LETTERS August 1981 
Table 2 
Hemagglutination-inhibition assays of the native and 
modified dog gastric mucus glycoproteins 
Sample Antigenic activitya 
Forssman A H 
Antral glycoprotein + + + 
Fundic glycoprotein + + + 
Forssman globopentaglycosyl- 
ceramide + + _ 
Delipidated glycoproteins of 
antrum and fundus + + + 
Defucosylated glycoproteins of 
antrum and fundus + •t - 
Antral and fundic glycoproteins 
treated with ol-N-acetyl- 
galactosaminidase _ _ + 
Alkali-degraded glycoproteins 
of antrum and fundus _ _ _ 
Alkalidegraded Forssman globo- 
pentaglycosylceramide •t + _ 
a The extent of Forssman activity of the native glycoproteins 
against 8 units of anti-Forssman antiserum was 6.2 -12.5 
w/O.1 ml and of Forssman globopentaglycosylceramide, 
1.8-3.6 ug/O.l ml. The A activity of glycoproteins against 
4 units of anti-A serum was 0.25 mg/O.l ml and H activity, 
against 2 units of anti-H lectin, 0.5 mg/O.l ml 
(+) signifies inhibition of agglutination; (-) indicates aggluti- 
nation 
anti-A and H anti-H system (table 2). Removal of 
fucose from glycoproteins resulted in the loss of 
H activity, but had no effect on their activity in 
human A anti-A system. Treatment of glycoproteins 
with o-N-acetylgalactosaminidase r sulted in the loss 
of both the Forssman and A antigenic activities. The 
Forssman and AH activities were also completely 
destroyed by the treatment of glycoproteins with 
alkali. The alkaline degradation, however, had no 
effect on Forssman globopentaglycosylceramide lipid. 
The above results suggest hat dog gastric mucus 
glycoproteins contain U-glycosidically linked carbo- 
hydrate chains which bear the Forssman antigenic 
determinant. 
4. Discussion 
Our previous studies on ABH antigens of gastric 
mucosa and gastric secretion established that in the 
mucosa these antigens are associated with glyco- 
sphingolipids, while those present in gastric secretion 
are glycoproteins [7,18]. These data, together with 
[4,5,14], clearly indicate that Forssman antigen in 
dog stomach is associated with both glycoproteins 
and glycosphingolipids. The glycosphingolipids bear- 
ing Forssman antigen are the integral part of the 
mucosa cell membranes, whereas glycoprotein antigen 
belongs to the secretion. Although the structural 
aspects of glycoprotein-associated Forssman antigen 
remains to be elucidated the results of enzymatic and 
immunological assays suggest hat these glycopro- 
teins, like Forssman glycosphingolipids, contain 
GalNAco_(l --, 3)GalNAc structure which determines 
the immunological specificity of Forssman antigen. 
This structure apparently resides on the non-reducing 
termini of oligosaccharide chains linked O-glycosidi- 
tally to the protein core. 
Since the observed A-activity of the glycoproteins 
was not affected by the removal of fucose, it is 
apparent that this activity derived from Forssman 
determinant and not from A antigen. The H-activity 
of the glycoproteins indicates that some of the oligo- 
saccharide chains of dog gastric mucus glycoproteins 
also carry cw-L-fucosyl-(I + 2)P-galactosyl residues. 
Whether these residues are the part of branched oligo- 
saccharide chains which also bear Forssman deter- 
minants remains to be determined. 
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